Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
33,235,472
-
Total 13F shares
-
22,505,448
-
Share change
-
-1,409,602
-
Total reported value
-
$250,711,399
-
Put/Call ratio
-
2.2%
-
Price per share
-
$11.14
-
Number of holders
-
98
-
Value change
-
-$19,749,903
-
Number of buys
-
67
-
Number of sells
-
35
Institutional Holders of NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) as of Q2 2025
As of 30 Jun 2025 NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) had 98 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 22,505,448 shares of stock of the company.
Largest 10 holders included ORBIMED ADVISORS LLC, MORGAN STANLEY, BlackRock, Inc., Soleus Capital Management, L.P., First Light Asset Management, LLC, VANGUARD GROUP INC, ARMISTICE CAPITAL, LLC, Driehaus Capital Management LLC, DEUTSCHE BANK AG\, and Kent Lake PR LLC.
This table shows 98 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.